Market Overview

NOVA MENTIS LIFE SCIENCES by Nova Mentis Life Sciences Corp. LIBFF:OTCPK OTCPK
Companies may follow the International Reporting Standard, Alternative Reporting Standard, or are current in the SEC reporting obligations.

{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists

Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic

0.1024 0 (0%)

Data as of Aug 12, 2020

Prev. Close 0.1024
Price Open
Volume 0
Day's Range -
52 Wk Range 0.01 - 0.14165
50 Day Moving Avg. 0.07
PE Ratio 0
Shares Outstanding 128.53M
Market Cap 13.16M

Trade LIBFF stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

Cannabis Stock Gainers And Losers From July 28, 2020 Jose Rodrigo SafdiyeTue, 28 Jul 2020 17:11:25 -0400
Stocks That Hit 52-Week Lows On Friday Lisa LevinFri, 01 Nov 2019 11:13:27 -0400
Stocks That Hit 52-Week Lows On Thursday Lisa LevinThu, 03 Oct 2019 13:03:21 -0400
Stocks That Hit 52-Week Lows On Tuesday Lisa LevinTue, 01 Oct 2019 14:35:15 -0400
Stocks That Hit 52-Week Lows On Wednesday Lisa LevinWed, 04 Sep 2019 11:39:22 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Liberty Leaf to Acquire Nova Mentis Biotech Corp. - Liberty Leaf Augments Portfolio with Entrance into the Emerging Psilocybin Therapy Market PRNewswireJun 22, 2020
Liberty Leaf Operations Update and COVID-19 Response PRNewswireApr 21, 2020
Signature by Liberty Leaf and Global Alliance Foundation Fund Sign Exclusive Veteran-Focussed Affiliate Partnership PRNewswireFeb 06, 2020
Signature by Liberty Leaf Now Approved to Support Direct Billing to Veterans Affairs Canada via Medavie Blue Cross PRNewswireJan 28, 2020
Liberty Leaf's Subsidiary Just Kush Enters Into Genetics Purchase & Services Agreement With Rubicon Organics PRNewswireDec 19, 2019
Liberty Leaf's Subsidiary Just Kush Announces Receipt of Cultivation, Processing and Medical Sales Licenses from Health Canada and Provides Corporate Update PRNewswireDec 16, 2019
Liberty Leaf Provides Update on the Just Kush Cannabis Facility PRNewswireNov 05, 2019
Cannvas Signs Definitive Contract with Liberty Leaf as Exclusive Cannabis Education Provider PRNewswireMay 28, 2019
Liberty Leaf Signs Definitive Contract with Cannvas to be its Exclusive Cannabis Education Provider PRNewswireMay 28, 2019
Liberty Leaf's Signature Cannabis Retail Launches Accessories Website PRNewswireApr 08, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

The Biggest Risk For Canopy Growth: Oversupply Seeking AlphaAug 29, 2018
Horizons Emerging Marijuana Growers ETF HMJR - 2018 Q2 Update Seeking AlphaJul 24, 2018
Weekly Cannabis Report: Molson Coors, Shopify, Tilray, Legal Sales Seeking AlphaJun 26, 2018
Weekly Cannabis Report: $2.1 Billion Shorts, Hydropothecary, Invictus Seeking AlphaMay 29, 2018
Complete Cannabis Guide #4: Provincial Regulations In Canada Seeking AlphaMay 23, 2018
Weekly Cannabis Report: Arb Trade, Hiku, Cronos, Namaste Seeking AlphaMay 21, 2018
Weekly Cannabis Report: Aurora/MedReleaf, Canopy, Maricann Seeking AlphaMay 15, 2018
Weekly Cannabis Report: MedReleaf Sell, TGOD IPO, Loblaw Wins Seeking AlphaMay 08, 2018
Weekly Cannabis Report: U.S. Federal Legalization And The Green Organic Dutchman's IPO Seeking AlphaMay 01, 2018
Weekly Cannabis Report: We Are Entering Cannabis 2.0 Seeking AlphaApr 24, 2018
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Company Profile

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.

Visit company website